BlueTree Venture Fund

BlueTree Venture Fund is a venture capital firm focused on early-stage investments in medical technologies, software, and high-tech instrumentation companies within a 250-mile radius. The firm aims to align its investments with the regional technology landscape and leverage its expertise to support portfolio companies. BlueTree Venture actively seeks businesses that showcase innovative technologies, possess strong management teams, and employ capital-efficient business strategies. The firm emphasizes opportunities for exit through strategic acquisitions, enabling it to provide hands-on mentorship and guidance to the companies it invests in.

Roger Byford

Managing Partner

David Motley

Managing Partner

Jon Pastor

Venture Partner

7 past transactions

Foundersuite

Series A in 2024
Foundersuite, Inc. is a software company that specializes in providing startup management tools for entrepreneurs. Founded in 2012 and based in San Francisco, the company offers a comprehensive suite of software solutions designed to streamline various aspects of startup operations. Its platform includes features such as the Investor CRM for managing investor relationships, a Progress Tracker to monitor company development, and a Startup Docs module that provides essential documents and templates for entrepreneurs. Additionally, Foundersuite offers an Investor Search tool to assist in identifying potential investors, as well as tools for email marketing and managing investor updates. The company's solutions aim to support startup founders in focusing on product development, sales, and team building while simplifying corporate housekeeping and fundraising efforts.

Cypris

Venture Round in 2024
Cypris is a New York City-based company founded in 2019 that specializes in providing accessible and actionable innovation data through a centralized platform. Its AI-powered technology consolidates information from a variety of sources, including global patents, research papers, and market news, enabling research and development teams to enhance their strategies. The platform aids clients in making informed decisions regarding acquisitions, patent filings, startup investments, and technology transfer agreements, ultimately driving financial impacts and facilitating the innovation process. By making complex data understandable and user-friendly, Cypris supports organizations in accelerating their R&D initiatives.

Cypris

Series A in 2023
Cypris is a New York City-based company founded in 2019 that specializes in providing accessible and actionable innovation data through a centralized platform. Its AI-powered technology consolidates information from a variety of sources, including global patents, research papers, and market news, enabling research and development teams to enhance their strategies. The platform aids clients in making informed decisions regarding acquisitions, patent filings, startup investments, and technology transfer agreements, ultimately driving financial impacts and facilitating the innovation process. By making complex data understandable and user-friendly, Cypris supports organizations in accelerating their R&D initiatives.

Instant Teams

Series A in 2022
Instant Teams is a technology-enabled company based in Rehoboth Beach, Delaware, specializing in providing remote workforce solutions. Founded in 2016, the company offers Arti, a platform that helps hiring managers define talent needs and matches pre-qualified, native English-speaking team members to projects. Instant Teams focuses on building high-quality customer support and operational teams, with a particular emphasis on military spouses and underserved talent communities, enabling 24/7 global support. The company's management platform handles payroll, compliance, time tracking, and reporting, making it a comprehensive solution for scaling and managing support operations. Notable customers include Walmart, Amazon, CrowdStrike, Assurance, and SeeSaw.

Peptilogics

Series A in 2017
Peptilogics, Inc. is a clinical-stage biotechnology company based in West Mifflin, Pennsylvania, founded in 2013. The company specializes in designing and developing novel peptide therapeutics aimed at addressing the urgent challenge of multidrug-resistant bacterial infections. Peptilogics utilizes a unique computational platform that enhances drug discovery by exploring new chemical design spaces while ensuring the biological viability and manufacturability of potential therapeutics. Their lead candidate, PLG0206, is a broad-spectrum anti-infective peptide that targets prosthetic joint infections and has received both FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation. Through its innovative eCAP (engineered cationic antibiotic peptide) platform, Peptilogics aims to provide effective treatment options against resistant bacteria and biofilms, ultimately improving patient outcomes and affordability in healthcare.

Iteros

Series A in 2017
Iteros is an energy software company that specializes in modeling, controlling, and managing sustainable energy systems. The company offers an end-to-end software platform designed to optimize distributed generation, energy storage, and other complementary distributed energy resource technologies. Its platform features modules for modeling and simulation, monitoring and visualization, and control and management. By leveraging proprietary code, Iteros enables customers to simulate the performance of energy assets, leading to more reliable and sustainable energy grids. This capability allows energy businesses to optimize the operation of their resources and ecosystems, ultimately reducing costs and maximizing returns on investment.

ALung

Series C in 2017
ALung Technologies, Inc., established in 1997 and based in Pittsburgh, Pennsylvania, specializes in developing and manufacturing medical devices for treating acute respiratory failure. The company's primary product is the Hemolung Respiratory Assist System, a dialysis-like device that removes carbon dioxide and delivers oxygen directly to the blood, allowing patients' lungs to rest and heal while avoiding intubation and facilitating protective ventilation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.